Skip to main
TRNS

Transcat (TRNS) Stock Forecast & Price Target

Transcat (TRNS) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Transcat Inc. is positioned favorably due to its majority revenue generation from its Service segment, which is expected to drive significant growth. The company's products, which include renowned brands like Extech and FLIR, enhance its appeal in the calibration and laboratory services market, contributing to expanding gross margins. Given the anticipated revenue growth and the overall demand for profitable companies with strong revenue and earnings visibility, there is a projected upside of approximately 30% from recent trading levels.

Bears say

Transcat Inc. faces several fundamental challenges that contribute to a negative outlook on its stock, including dilution risk from potential capital raises, significant customer concentration, and the complexities associated with acquisition integration. Furthermore, the company is experiencing heightened competition from web-based retailers within its distribution segment, which poses a threat to its market position. Additionally, share volatility stemming from the small capitalization and lower liquidity further complicates the financial stability and attractiveness of Transcat’s stock.

Transcat (TRNS) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Transcat and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Transcat (TRNS) Forecast

Analysts have given Transcat (TRNS) a Strong Buy based on their latest research and market trends.

According to 2 analysts, Transcat (TRNS) has a Strong Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Transcat (TRNS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.